Markets
China SXT Pharmaceuticals, Inc. (SXTC)
SXTCNASDAQ-CMN/A
$3.13
+0.3300 (+11.79%) today
Closed, Nov 9, 4:00 PM ET
+11.79% 1D
- Market cap
- $321.1k
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- –
- Average volume
- –
- Previous close
- $2.80
Financials
| Quarter | Mar 2016 | Mar 2018 |
|---|---|---|
| Revenue | $3.72m | $1.43m |
| Gross profit | $794.0k | $812.0k |
| Operating income | $209.0k | $300.0k |
| Net income | $142.0k | $182.0k |
News
8 latest- China SXT Pharmaceuticals Announces 1-for-100 Share Consolidation; Stock Down RTTNews · Oct 22, 2026
- China SXT Pharmaceuticals, Inc. Announces Termination of $12,000,000 Over-Allotment OptionFintel · Oct 22, 2026
- Biotech Stocks Move Higher: IMNN Surges Over 18%, HSCS Gains Over 13%, SXTC Rises 7% RTTNews · Oct 21, 2026
- China SXT Secures $12 Million Financing Through Registered Direct Offering; Stock Down RTTNews · Oct 8, 2026
- Biotech Stocks In Focus - SXTC +536% On Sharp Move; VRXA, AVBP, SPRC On Key Developments RTTNews · Oct 7, 2026
- Why SXTC Shares Surge? RTTNews · Feb 2, 2026
- After-Hours Biotech Rally: SXTC, RPID, TGTX Lead Gains On Revenue Updates, And FDA Milestones RTTNews · Jan 13, 2026
- After-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers RTTNews · Jan 11, 2026
The company
Founded in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional Chinese Medicine that has been processed to be ready for use.
- Sector
- N/A
- Industry
- N/A
- Exchange
- NASDAQ-CM
- Region
- Asia
- Website
- sxtchina.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.